An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers-Reference-Cited by-同舟云学术

An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers

Published:2023-04 Issue:4 Volume:31 Page:1033-1045
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Zekri Latifa^ORCID,Lutz Martina,Prakash Nisha,Manz Timo,Klimovich Boris,Mueller Stefanie,Hoerner Sebastian,Hagelstein Ilona,Engel Monika,Chashchina Anna,Pfluegler Martin,Heitmann Jonas S.,Jung Gundram,Salih Helmut R.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference54 articles.

1. Bispecific antibodies: a mechanistic review of the pipeline;Labrijn;Nat. Rev. Drug Discov.,2019

2. Bispecific antibodies: design, therapy, perspectives;Sedykh;Drug Des. Devel. Ther.,2018

3. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

4. T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments;Daver;Leukemia,2021

5. Bispecific antibodies;Kontermann;Drug Discov. Today,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in immunotherapy for gastrointestinal tract cancers;Journal of Hematology & Oncology;2024-08-09

2. Modified heated CGMD simulations for discovering stable docked conformations of BiTE antibody against CD3 and CD117/c-kit;Molecular Simulation;2024-07-24

3. Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia;Cancers;2024-07-04

4. The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas;Frontiers in Immunology;2024-05-03

5. NR1D1‐transactivated lncRNA NUTM2A‐AS1 promotes chemoresistance and immune evasion in neuroblastoma via inhibiting B7‐H3 degradation;Journal of Cellular and Molecular Medicine;2024-05